Genesystem Co., Ltd. (KOSDAQ: 363250)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,550.00
+580.00 (6.47%)
Sep 11, 2024, 9:00 AM KST
-67.29%
Market Cap 66.91B
Revenue (ttm) 1.57B
Net Income (ttm) -11.27B
Shares Out 7.01M
EPS (ttm) -1,623.49
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 39,129
Open 9,000.00
Previous Close 8,970.00
Day's Range 9,000.00 - 9,660.00
52-Week Range 5,390.00 - 31,900.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About Genesystem

Genesystem Co., Ltd., a biotech engineering company, specializes in molecular testing solutions to target on-site testing needs. The company offers PCR systems, multiplex biochips, and PCR reagents. It also provides human pathogen assays, including novel coronavirus (SARS-CoV-2) detection kits, SARS-CoV-2/Flu/RSV simultaneous detection kits, and mycobacterium tuberculosis detection kits; veterinary diagnostics; food safety assays comprising foodborne pathogen detection kits, HALAL food testing kits, and meat species identification kits; and nuc... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 363250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.